CLIENT CASE
Biotech’s omnichannel consent strategy for EU Launch
Our user-friendly SaaS-based solution, originated in Pharma & Life Sciences, helps you easily manage consented HCP across different channels.
Situation
Biotech is determined to expand its outreach to specialists specializing in rare diseases and is about to launch in Europe. Their target group consists of more than 100k potential HCPs across Europe. Their field force is limited, so that the speed at which they want to collect consent and accelerates digital interaction is too low. To overcome this challenge, they are actively exploring alternative ways to enhance their promotion through additional (digital) channels. The objective is to create an omni-channel commercial operating model for gathering consent, leveraging resources such as their website, congress events with QR codes, and more. Once the consent is collected, its status needs to be stored in a central repository according to (local) data protection rules, ensuring seamless alignment with the data stored in Veeva CRM.
Challenge
Biotech needs to confront the following critical challenges head-on:
01
We must establish a central consent management system to capture, collect and manage opt-ins and opt-outs according to GDPR requirements.
02
Veeva is inadequate for orchestrating this process, as it primarily supports in-person interactions. However, they require that Veeva users have immediate access to opt-in and opt-out statuses collected through other channels, enabling them to make informed decisions about sending rep-triggered emails.
03
They cannot afford duplicate records that arise from utilizing different channels, as this leads to unnecessary manual work and delays in our follow-up actions with healthcare professionals. We will ensure effective communication between the opt-ins and opt-outs collected through all channels (digital and non-digital) and the records in the CRM, allowing Key Account Managers (KAMs) to see all relevant opt-in and opt-out statuses in real-time.
04
They are committed to broadening our outreach to this target group by significantly increasing the number of opt-ins, which will serve as a vital gateway for enhanced digital communication and not losing momentum regards launching.
Implemented Solution by OptInsight in four months
Drawing from our experience with similar cases, we proposed a comprehensive, turnkey solution that includes:
- A centralized consent and data management system that synchronizes consent data bi-directionally between the designated web form/online page and Veeva. This will significantly reduce manual tasks and enhance the availability of consent data within Veeva.
- Scalable digital consent forms designed to efficiently collect consent and healthcare professional data, deployable via websites, congresses, and QR codes. This will include confirmation emails for both opt-ins and opt-outs across various countries, ensuring a streamlined and efficient process.
- Start with collection of consent via a third party call center (strategic partner of OptInsight which resulted in > 50% consents initially
”HCPs communicate more and more via digital channels. I lost control over the actual opt-in and opt-out status and evidence, resulting in a compliance risk for our company. OptInsight acts like a sort of octopus, allowing us to take into account consent via other systems we use, such as OCE (CRM).
CLIENT REVIEW
Curious?
Schedule a meeting with us.
Tip: involve your colleagues from other departments within your company. In this way we can instantly answer questions and provide clarity from various points of view.
